BTI
IMVT icon

Blue Trust Inc’s Immunovant IMVT Stock Holding History

Blue Trust Inc’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$795 Hold
32
– – ﹤0.01% 2290
2025
Q4 		$813 Hold
32
– – ﹤0.01% 2323
2025
Q3 		$516 Hold
32
– – ﹤0.01% 2422
2025
Q2 		$512 Sell
32
-370
-92% -$5.59K ﹤0.01% 2318
2025
Q1 		$6.87K Hold
402
– – ﹤0.01% 2039
2024
Q4 		$9.96K Buy
402
+318
+379% +$9.02K ﹤0.01% 1873
2024
Q3 		$2.22K Sell
84
-71
-46% -$2.09K ﹤0.01% 2565
2024
Q2 		$5.01K Buy
+155
New +$4.41K ﹤0.01% 2204

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Blue Trust Inc's IMVT Position: Q1 2026 in Review

Blue Trust Inc held its Immunovant (IMVT) position steady in Q1 2026 at 32 shares worth $795. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Blue Trust Inc first reported a position in IMVT in Q2 2024 and has held it in 8 quarters since. The position peaked at $9.96K in Q4 2024. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Blue Trust Inc held 32 shares of Immunovant worth $795 as of Q1 2026.
  • Blue Trust Inc left its Immunovant share count unchanged in Q1 2026.
  • Immunovant made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #2290 holding.
  • Blue Trust Inc first reported a position in Immunovant in Q2 2024 and has held it in 8 quarters since.
  • Blue Trust Inc's Immunovant position peaked at $9.96K in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.